.png){kind=logo}
₹ 283200
₹110- ₹118
1200
₹120
1.69
14 Aug 2026
Download18 Aug 2026
19 Aug 2026
Application Details
Pramodini Medicare IPO is a book build issue of ₹69.04 crores. The issue is a combination of fresh issue of 0.54 crore shares aggregating to ₹63.14 crores and offer for sale of 0.05 crore shares aggregating to ₹5.90 crores.
Pramodini Medicare IPO opens for subscription on Aug 12, 2026 and closes on Aug 14, 2026. The allotment for the Pramodini Medicare IPO is expected to be finalized on Aug 17, 2026. Pramodini Medicare IPO will list on the NSE SME with a tentative listing date fixed as Aug 19, 2026.
Pramodini Medicare IPO is set issue price band at ₹110 to ₹118 per share. The lot size for an application is 1,200 shares. The minimum amount of investment required by an individual investor (retail) is ₹2,83,200 (2,400 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (3,600 shares), amounting to ₹4,24,800.
Smart Horizon Capital Advisors Pvt.Ltd. is the book running lead manager and Purva Sharegistry (India) Pvt.Ltd. is the registrar of the issue. The Market Maker of the company are Rainbow Securities Pvt.Ltd., Shreni Shares Ltd.
About Pramodini Medicare (SME)
Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments. The company provides services to public hospitals, private hospitals, public sector undertakings (PSUs), medical colleges, and private diagnostic centres across tier I, II, and III cities.
Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour doppler, mammography, Dexa scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy. The company also operates a 24×7 teleradiology unit from Vijayawada and a processing laboratory at the same location.
Service Model
- Public-Private Partnership (PPP): Operates diagnostic centres within government hospitals and medical colleges through long-term MOUs.
- Private-Private Partnership (Pvt-Pvt): Establishes and manages diagnostic centres inside private hospitals under partnership agreements.
- Strategic Partnerships with PSUs: Collaborates with Government of India PSUs to operate diagnostic and imaging centres across multiple states.
- Standalone Diagnostic Centres: Operates its own diagnostic centres and laboratories, serving both individual patients and hospitals.
- Location-Specific Agreements: Each diagnostic centre operates under separate MOUs or contracts with terms customized for the respective location.
The business operates through four models: public-private partnership (PPP) with government hospitals and teaching institutions, private-private partnerships with hospitals, strategic partnerships with PSUs, and standalone private diagnostic centres. As of August 04, 2026, the company operated 16 diagnostic centres across seven states.
As of March 31, 2026, the company had 161permanent employees.
Competitive Strengths:
- Establishing a strategic presence across various states of India.
- Strengthening its network through diversified business models.
- Strong technical capabilities supported by robust IT infrastructure.
- Experienced management team with significant industry expertise.
- Consistent track record of revenue growth and financial performance.
- Diverse customer base, including hospitals, institutions, and individual patients.
FAQ
IPO stands for "Initial Public Offering." It's the process through which a privately-held company becomes publicly traded by offering its shares to the general public and listing them on a stock exchange for trading. This allows the company to raise capital from investors and grants individuals and institutions the opportunity to invest in and own a portion of the company.
The life cycle of an IPO, or Initial Public Offering, begins with a company's decision to go public. It involves hiring underwriters, registering with regulatory authorities, determining the IPO price, marketing to investors, and the subscription period where investors place orders for shares. After allocation and listing, shares become publicly tradable, and the company enters the secondary market. Ongoing reporting and corporate governance are crucial as the company continues to operate as a publicly-traded entity. The IPO aims to raise capital for growth and provides investors with opportunities to trade shares in the company.
An IPO (Initial Public Offering) is when a private company goes public by selling shares to the public. Investors buy these shares, giving them ownership in the company. It's a way for companies to raise capital and expand. The process involves underwriters, regulatory filings, setting the IPO price, and marketing to investors. After the IPO, shares can be traded on a stock exchange. IPOs offer opportunities and risks, so investors should research and consider carefully.
"Upcoming IPOs" refers to initial public offerings that have been announced by private companies but have not yet occurred. These are companies that plan to go public in the near future by issuing shares to the public and listing them on a stock exchange. Investors often keep an eye on upcoming IPOs as they represent opportunities to invest in companies at their early stages of public trading, potentially capturing growth potential. These offerings are typically accompanied by significant media and investor attention as they approach their launch dates.